127 related articles for article (PubMed ID: 6466571)
1. Acute leukaemia in patients treated for Hodgkin's disease.
Papa G; Mauro FR; Anselmo AP; Cimino G; Alimena G; Amadori S; D'Arcangelo E; Giannarelli D; Bosi A; Bellesi G
Br J Haematol; 1984 Sep; 58(1):43-52. PubMed ID: 6466571
[TBL] [Abstract][Full Text] [Related]
2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
3. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
[TBL] [Abstract][Full Text] [Related]
4. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.
Cimino G; Papa G; Tura S; Mazza P; Rossi Ferrini PL; Bosi A; Amadori S; Lo Coco F; D'Arcangelo E; Giannarelli D
J Clin Oncol; 1991 Mar; 9(3):432-7. PubMed ID: 1999712
[TBL] [Abstract][Full Text] [Related]
5. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
[TBL] [Abstract][Full Text] [Related]
6. Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
J Clin Oncol; 1986 Jun; 4(6):830-7. PubMed ID: 3711960
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease terminating in acute leukaemia: report of seven cases.
Wolf MM; Cooper IA; Ding JC
Aust N Z J Med; 1979 Aug; 9(4):398-402. PubMed ID: 292379
[TBL] [Abstract][Full Text] [Related]
8. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
[TBL] [Abstract][Full Text] [Related]
9. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
10. [Acute leukemia in patients treated for Hodgkin's disease].
Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
[No Abstract] [Full Text] [Related]
11. The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease.
Mendenhall NP; Shuster JJ; Million RR
Radiother Oncol; 1989 Mar; 14(3):219-29. PubMed ID: 2710953
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
Lipton JH; Gospodarowicz M; Reingold S
Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
[TBL] [Abstract][Full Text] [Related]
13. Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.
Devereux S; Selassie TG; Vaughan Hudson G; Vaughan Hudson B; Linch DC
BMJ; 1990 Nov; 301(6760):1077-80. PubMed ID: 2249071
[TBL] [Abstract][Full Text] [Related]
14. How relevant is secondary leukaemia for initial treatment selection in Hodgkin's disease?
Hess CF; Kortmann RD; Schmidberger H; Bamberg M
Eur J Cancer; 1994; 30A(10):1441-7. PubMed ID: 7833099
[TBL] [Abstract][Full Text] [Related]
15. Secondary leukemia following treatment of Hodgkin's disease: ultrastructural and cytogenetic data in two cases with a review of the literature.
Yahalom J; Voss R; Leizerowitz R; Fuks Z; Polliack A
Am J Clin Pathol; 1983 Aug; 80(2):231-6. PubMed ID: 6349327
[TBL] [Abstract][Full Text] [Related]
16. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease and acute leukemia. Is it a true association?
Avilés A; Díaz-Maqueo JC; Ayala JR; Cortés HD; García EL
Arch Med Res; 1992; 23(1):65-8. PubMed ID: 1308794
[TBL] [Abstract][Full Text] [Related]
18. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
Tura S; Fiacchini M; Zinzani PL; Brusamolino E; Gobbi PG
J Clin Oncol; 1993 May; 11(5):925-30. PubMed ID: 8487056
[TBL] [Abstract][Full Text] [Related]
19. Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's disease.
Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Sbarbati S; Tombolini V; Mandelli F; D'Arcangelo E; Biagini C
Ann Hematol; 1997 Mar; 74(3):103-10. PubMed ID: 9111422
[TBL] [Abstract][Full Text] [Related]
20. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
